Ameriprise’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.6M Buy
329,602
+1,009
+0.3% +$59.3K ﹤0.01% 1499
2025
Q4
$20.5M Sell
328,593
-512
-0.2% -$31.6K ﹤0.01% 1397
2025
Q3
$19.8M Sell
329,105
-8,133
-2% -$497K ﹤0.01% 1409
2025
Q2
$21.1M Sell
337,238
-27,060
-7% -$1.63M 0.01% 1321
2025
Q1
$21.9M Buy
364,298
+36,610
+11% +$2.27M 0.01% 1250
2024
Q4
$19.1M Sell
327,688
-18,196
-5% -$1.08M ﹤0.01% 1362
2024
Q3
$20.5M Sell
345,884
-67,190
-16% -$3.84M 0.01% 1319
2024
Q2
$23.2M Sell
413,074
-67,709
-14% -$3.79M 0.01% 1190
2024
Q1
$28.2M Sell
480,783
-47,196
-9% -$2.67M 0.01% 1097
2023
Q4
$28.5M Sell
527,979
-74,496
-12% -$3.64M 0.01% 1071
2023
Q3
$29.2M Buy
602,475
+15,769
+3% +$838K 0.01% 1001
2023
Q2
$33.1M Sell
586,706
-12,757
-2% -$703K 0.01% 961
2023
Q1
$32.4M Sell
599,463
-46,966
-7% -$2.5M 0.01% 964
2022
Q4
$34M Sell
646,429
-42,886
-6% -$2.18M 0.01% 907
2022
Q3
$32.5M Sell
689,315
-793,586
-54% -$41.2M 0.01% 885
2022
Q2
$74.8M Buy
1,482,901
+73,793
+5% +$4.02M 0.03% 585
2022
Q1
$86M Buy
1,409,108
+388,407
+38% +$23.2M 0.03% 585
2021
Q4
$67.2M Buy
1,020,701
+44,187
+5% +$2.83M 0.02% 717
2021
Q3
$61.3M Sell
976,514
-13,102
-1% -$836K 0.02% 672
2021
Q2
$59.6M Sell
989,616
-319,296
-24% -$18.5M 0.02% 717
2021
Q1
$72.3M Sell
1,308,912
-233,622
-15% -$13M 0.02% 614
2020
Q4
$84.2M Buy
1,542,534
+73,614
+5% +$3.85M 0.03% 532
2020
Q3
$73.4M Sell
1,468,920
-77,274
-5% -$3.74M 0.03% 508
2020
Q2
$68.3M Buy
1,546,194
+599,700
+63% +$25.6M 0.03% 507
2020
Q1
$35.6M Buy
946,494
+83,112
+10% +$3.5M 0.02% 670
2019
Q4
$37.8M Buy
863,382
+274,776
+47% +$11.6M 0.02% 827
2019
Q3
$24.3M Buy
588,606
+58,260
+11% +$2.39M 0.01% 1003
2019
Q2
$21.3M Sell
530,346
-15,186
-3% -$575K 0.01% 1117
2019
Q1
$21.1M Buy
545,532
+72,396
+15% +$2.63M 0.01% 1091
2018
Q4
$15.8M Buy
473,136
+81,822
+21% +$2.83M 0.01% 1215
2018
Q3
$58.2M Buy
391,314
+114,810
+42% +$4.08M 0.02% 676
2018
Q2
$9.25M Buy
276,504
+90,132
+48% +$2.94M ﹤0.01% 1807
2018
Q1
$5.64M Buy
186,372
+118,896
+176% +$3.66M ﹤0.01% 2089
2017
Q4
$1.95M Buy
67,476
+8,622
+15% +$249K ﹤0.01% 2664
2017
Q3
$1.64M Buy
58,854
+16,746
+40% +$463K ﹤0.01% 2709
2017
Q2
$1.17M Buy
42,108
+6,744
+19% +$179K ﹤0.01% 2872
2017
Q1
$892K Buy
35,364
+2,718
+8% +$65.9K ﹤0.01% 2951
2016
Q4
$724K Sell
32,646
-155,004
-83% -$3.52M ﹤0.01% 3116
2016
Q3
$4.54M Buy
187,650
+114,102
+155% +$2.71M ﹤0.01% 2068
2016
Q2
$1.66M Buy
73,548
+58,566
+391% +$1.27M ﹤0.01% 2620
2016
Q1
$306K Buy
14,982
+4,386
+41% +$85.2K ﹤0.01% 3355
2015
Q4
$216K Buy
+10,596
New +$212K ﹤0.01% 3627
2014
Q4
Sell
-5,334
Closed -$88K 4045
2014
Q3
$88K Hold
5,334
﹤0.01% 3730
2014
Q2
$91K Buy
5,334
+1,908
+56% +$31.2K ﹤0.01% 3622
2014
Q1
$56K Sell
3,426
-102
-3% -$1.64K ﹤0.01% 3744
2013
Q4
$55K Hold
3,528
﹤0.01% 3619
2013
Q3
$50K Sell
3,528
-42
-1% -$577 ﹤0.01% 3812
2013
Q2
$47K Buy
+3,570
New +$46.3K ﹤0.01% 3743

Other funds holding IHI

Ameriprise's IHI Position: Q1 2026 in Review

Ameriprise increased its iShares US Medical Devices ETF (IHI) stake by 0.31% in Q1 2026, buying an estimated $59.3K and bringing the position to 329,602 shares worth $17.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1499.

Ameriprise first reported a position in IHI in Q2 2013 and has held it in 48 quarters since. The position peaked at $86M in Q1 2022. 503 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

  • Ameriprise held 329,602 shares of iShares US Medical Devices ETF worth $17.6M as of Q1 2026.
  • Ameriprise bought 1,009 iShares US Medical Devices ETF shares in Q1 2026, an estimated $59.3K.
  • iShares US Medical Devices ETF made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #1499 holding.
  • Ameriprise first reported a position in iShares US Medical Devices ETF in Q2 2013 and has held it in 48 quarters since.
  • Ameriprise's iShares US Medical Devices ETF position peaked at $86M in Q1 2022.
  • 503 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.